ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

This study has been completed.
Study NCT00067080.   Last updated on September 25, 2007.   Information provided by Novartis
Please refer to this study by its ClinicalTrials.gov identifier: NCT00067080


Locations
United States, Alabama
U. of S. Alabama Medical Center    
      Mobile, Alabama, United States, 36604
United States, California
Children's Hospital & Research Center    
      Oakland, California, United States, 94609
Children's Hospital Los Angeles    
      Los Angeles, California, United States, 90027
Loma Linda University Medical Center    
      Loma Linda, California, United States, 92354
United States, Colorado
Colorado Sickle Cell Treatment and Research Center    
      Denver, Colorado, United States, 80262
United States, District of Columbia
Howard University Hospital    
      Washington, District of Columbia, United States, 20059
United States, Florida
Tampa Children's Hospital at St Joseph's    
      Tampa, Florida, United States, 33607
United States, Georgia
Adult Sickle Cell Clinic, Medical College of Georgia    
      Augusta, Georgia, United States, 30912
Georgia Comprehensive Sickle cell Center, Grady Hospital    
      Atlanta, Georgia, United States, 30335
United States, Illinois
University of Illinois at Chicago    
      Chicago, Illinois, United States, 60612
Children's Memorial Hospital    
      Chicago, Illinois, United States, 60614
United States, Louisiana
Tulane University Sickle Cell Center    
      New Orleans, Louisiana, United States, 70112
Children's Hospital, Department of Hematology/Oncology    
      New Orleans, Louisiana, United States, 70118
United States, Massachusetts
Boston Medical Center    
      Boston, Massachusetts, United States, 02118
Children's Hospital Boston, Division of Hematology/Oncology    
      Boston, Massachusetts, United States, 02115
United States, Michigan
Karmanos Cancer Institute    
      Detroit, Michigan, United States, 48201
United States, New York
NY Methodist Hospital    
      Brooklyn, New York, United States, 11215
Sickle Cell Center, Montefiore Hospital    
      Bronx, New York, United States, 10467
U. Of Rochester Medical Center    
      Rochester, New York, United States, 14642
Weill Medical College of Cornell University    
      New York, New York, United States, 10021
United States, North Carolina
Wake Forest University School of Medicine    
      Winston-Salem, North Carolina, United States
United States, Ohio
Children's Hospital Medical Center    
      Cincinnati, Ohio, United States, 45229
James Cancer Hospital    
      Columbus, Ohio, United States, 43210
Barrett Center, University of Cincinnati    
      Cincinnati, Ohio, United States, 45219
United States, Pennsylvania
Children's Hospital of Pittsburgh    
      Pittsburgh, Pennsylvania, United States, 15213
Penn State Milton S Hershey Medical Center    
      Hershey, Pennsylvania, United States, 17033
Children's Hospital of Philadelphia    
      Philadelphia, Pennsylvania, United States, 19104
United States, South Carolina
Santee Hematology/Oncology    
      Sumter, South Carolina, United States, 29150
Palmetto Health Clinical Trials    
      Columbia, South Carolina, United States, 29203
Liberty Hematology Oncology Center    
      Columbia, South Carolina, United States, 29203
United States, Texas
Baylor College of Medicine    
      Houston, Texas, United States, 77030
Scott and White Memorial Hospital & Clinics    
      Temple, Texas, United States, 76508
Texas Children's Hospital/Baylor College of Medicine    
      Houston, Texas, United States, 77030
United States, Virginia
Children's Hospital of the King's Daughter    
      Norfolk, Virginia, United States, 23507

Sponsors and Collaborators
Novartis

Investigators
Study Chair:     Novartis     Novartis    





Links to all studies - primarily for crawlers